DLM and adjacent DTCbN project to Area X. a–d,
case where injection was mostly in DLM. Synaptophysin-GFP label was evident in
Area X (for example see white arrowhead in d)
e–h, case where injection was in DLM and surrounding
DTCbN. Synaptophysin-GFP label was evident in medial striatum
(G and H, white arrow) and in Area X
(h, white arrowhead). i–l, case where
injection was mostly in DTCbN. Although the injection was mainly in
DTCbN, we again saw strong synaptophysin-GFP label in Area X (for
example k, white arrowhead). a,e,y, Injection sites.
Orange region, DLM; cyan region, DTCbN; magenta, cell bodies
expressing mCherry. b–d, f–h, j–l. Series
of sections from lateral to medial showing Area X, surrounding medial striatum,
and overlying nidopallium. Green, GFP signal. Magenta, mCherry signal. Dark
gray, no parvalbumin label; gray, some parvalbumin label; light gray, strong
parvalbumin label. White arrowheads, examples of GFP signal in Area X; solid
white arrow, GFP signal outside Area X in MSt; black arrow with white outline,
GFP signal in nidopallium. DLM, dorsolateral thalamus, medial part. MAN,
magnocellular nucleus of anterior nidopallium. MSt, medial striatum. nido,
nidopallium. Ov, nucleus ovoidalis. PC, posterior commissure. SpM, medial
spiriform nucleus. To facilitate comparison across cases, distances from midline
for injection sites are based on the map of DLM and DTCbN we created
as described in Methods. All sections are parasagittal, left is anterior and up
is dorsal. All scale bars 500 μm.